Vaccines for Kids, a Global Surge in Cases, and More Coronavirus News

Vaccinating children spurs controversy, the Delta variant fuels a global surge, and drugmakers and countries consider boosters. Here’s what you should know:

Want to receive this weekly roundup and other coronavirus news? Sign up here!

Headlines

Vaccinating kids is poised to be the next politicized pandemic issue in the US

This week, Tennessee fired its top vaccine official for notifying health care providers of a long-standing legal mechanism that allows minors over 14 to be vaccinated without parental consent. The state has also stopped all online vaccination outreach to teens. This news, coupled with the CDC’s recent relaxation of guidelines for wearing masks inside school buildings, could well be an omen of the next big Covid controversy: vaccinating children. Clinical trials testing mRNA vaccines for kids are well underway, and first requests for emergency authorization are expected in September or October. But if they’re approved, shots for kids seem likely to become a political battleground rife with misinformation.

On Thursday, US surgeon general Vivek Murthy called misinformation about Covid-19 and vaccines more generally a pressing national concern, especially as vaccination rates have slowed and cases are once again on the rise. He called on tech companies in particular to make changes to their platforms to stop the spread of unfounded or inaccurate claims about the pandemic.

The Delta variant continues to spur a surge in cases around the world and in the US

get more information
get redirected here
get the facts
go
go here
go now
go right here
go to the website
go to these guys
go to this site
go to this web-site
go to this website
go to website
go!!
going here
good
great post to read
great site
had me going
have a peek at these guys
have a peek at this site
have a peek at this web-site
have a peek at this website
have a peek here
he has a good point
he said
helpful hints
helpful resources
helpful site
her comment is here
her explanation
her latest blog
her response
here
here are the findings
here.
his comment is here
his explanation
his response
home
home page
homepage
hop over to here
hop over to these guys
hop over to this site
hop over to this web-site
hop over to this website
how much is yours worth?
how you can help
i loved this
i thought about this
i was reading this
image source
in the know
index
informative post
inquiry
internet
investigate this sitekiller deal
knowing it
learn here
learn more
learn more here
learn the facts here now
learn this here now
like it
like this
link
[link]
linked here
listen to this podcast
look at here
look at here now
look at more info
look at these guys
look at this
look at this now
look at this site
look at this web-site
look at this website

Global outbreaks are worsening as the Delta variant continues to spread rapidly. The WHO reported that deaths in Africa rose by 43 percent in the last week, South Korea has tightened restrictions as it battles its worst outbreak yet, and Covid wards are overflowing in Indonesia, the world’s fourth-most-populous country. The surge is particularly bad in countries with lower vaccination rates, but fortunately some vaccine sharing efforts seem to be picking up speed. Late this week, for instance, Indonesia received 1.5 million doses of the Moderna vaccine following 3 million other American doses that arrived last weekend.

Delta is now also the dominant strain in the US, and case counts are going up in every state. In response to this surge, Los Angeles reinstated its indoor mask mandate for everyone—vaccinated or not.

Some countries weigh offering booster shots despite calls to prioritize first doses

Israel has started offering a third booster dose of the Pfizer-BioNTech vaccine to immunocompromised adults after the Delta variant sent case rates up again, even among people who have already been vaccinated. The country’s health minister said the decision on whether to make boosters more widely available is pending. Pfizer has been pitching boosters in the US as well, but senior US officials told the drugmaker that they would need more data on the efficacy of a third dose before approving it for use. Even so, a federal advisory panel is expected to meet next week to weigh the possibility of giving additional doses to patients with suppressed immunity.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *